J. Bodle

发表

Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine

I. Barr, S. Rockman, S. Lowther, 2013, Journal of Virology.

Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine.

I. Wang, R. Cristescu, A. Loboda, 2012, Vaccine.

Neuraminidase-inhibiting antibody is a correlate of cross-protection 2 against lethal H 5 N 1 influenza in ferrets immunised with seasonal influenza 3 vaccine

I. Barr, S. Rockman, S. Lowther, 2013 .

Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial

A. Wheatley, J. Hickling, S. Rockman, 2020, PLoS medicine.

Cellular responses at the application site of a high-density microarray patch delivering an influenza vaccine in a randomized, controlled phase I clinical trial

J. Hickling, S. Rockman, M. Veitch, 2021, PloS one.

Native North American Azolla Weevil, Stenopelmus rufinasus (Coleoptera: Curculionidae), Uses the Invasive Old World Azolla pinnata as a Host Plant

R. Pemberton, J. Bodle, 2009 .

An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines

I. Barr, K. Laurie, S. Rockman, 2023, Frontiers in Immunology.

Development of an enzyme‐linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion

I. Barr, S. Rockman, C. Ong, 2012, Influenza and other respiratory viruses.

Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).

I. Frazer, J. Hickling, S. Rockman, 2018, Vaccine.

Investigation into alternative testing methodologies for characterization of influenza virus vaccine

S. Rockman, T. Tay, C. Agius, 2015, Human vaccines & immunotherapeutics.

Assessing the stability-indicating properties of alternative potency assays for inactivated influenza vaccine.

M. Eichelberger, S. Rockman, O. Engelhardt, 2023, Vaccine.

Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).

I. Frazer, J. Hickling, S. Rockman, 2018, Vaccine.